tiprankstipranks
Trending News
More News >
Telix Pharmaceuticals Ltd. (AU:TLX)
ASX:TLX

Telix Pharmaceuticals (TLX) Revenue

Compare
321 Followers

Telix Pharmaceuticals Revenue

Telix Pharmaceuticals had a revenue of 594.24M in the quarter ending Dec 31, 2024, with 214.48%. This bring the company's revenue in the last twelve months to 783.21M, Decreased 66.40%. In the fiscal year ending Dec 31, 2024, Telix Pharmaceuticals had annual revenue of 783.21M with 55.85% growth.
Revenue (ttm)
783.21M
Revenue Growth
55.85%
P/S Ratio
11.22
Revenue/Employee
$1,887,246
Employees
415
Market Cap
$8.79B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
783.21M280.66M+55.85%
Dec 31, 2023
502.55M342.45M+213.90%
Dec 31, 2022
160.10M152.50M+2,007.64%
Dec 31, 2021
7.60M2.38M+45.71%
Dec 31, 2020
5.21M1.73M+49.58%
Dec 31, 2019
3.48M3.29M+1,685.88%
Dec 31, 2018
195.14K+∞%
Dec 31, 2017
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis